Top Markets
Coin of the day
GridAI Technologies Corp. GridAI Technologies Corp.

GridAI Technologies Corp.

GRDX
Rank in Stocks #31432
GridAI Technologies Corp. functions as a clinical-stage biopharmaceutical... GridAI Technologies Corp. functions as a clinical-stage biopharmaceutical enterprise primarily dedicated to developing precise, locally-acting treatments for various digestive system ailments. Its core activity involves researching and advancing therapeutic solutions specifically designed for patients with gastrointestinal diseases. The company's pipeline features several key drug candidates, including Latiglutenase, Capeserod, Adrulipase, and Niclosamide. GridAI Technologies was established on January 30, 2014, and maintains its principal offices in Boca Raton, Florida.
Share Price
$4.11
Market Cap
$13.80M
Change (1 day)
3.92%
Change (1 year)
90.05%
Country
US
Trade GridAI Technologies Corp. (GRDX)

Category

Operating Margin for GridAI Technologies Corp. (GRDX)
Operating Margin as of 2026 TTM: 0.00%
According to GridAI Technologies Corp. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for GridAI Technologies Corp. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
38.59% -
US
28.81% -
NL
25.72% -
AU
0.00% -
CH
31.23% -
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.